

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.23470840 |
| 2 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.04864832 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 4.68612728 |
| 4 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.46237308 |
| 5 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.09146494 |
| 6 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.08503369 |
| 7 | chaperone-mediated protein transport (GO:0072321) | 3.92341017 |
| 8 | viral transcription (GO:0019083) | 3.88459540 |
| 9 | DNA strand elongation (GO:0022616) | 3.85790119 |
| 10 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.82466241 |
| 11 | translational termination (GO:0006415) | 3.78846953 |
| 12 | formation of translation preinitiation complex (GO:0001731) | 3.78436184 |
| 13 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.77934305 |
| 14 | DNA replication initiation (GO:0006270) | 3.66359457 |
| 15 | telomere maintenance via recombination (GO:0000722) | 3.56854585 |
| 16 | translational elongation (GO:0006414) | 3.54929911 |
| 17 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.53425155 |
| 18 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.51246297 |
| 19 | protein targeting to membrane (GO:0006612) | 3.47725817 |
| 20 | maturation of SSU-rRNA (GO:0030490) | 3.44683346 |
| 21 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.39171138 |
| 22 | protein maturation by protein folding (GO:0022417) | 3.39043532 |
| 23 | protein localization to kinetochore (GO:0034501) | 3.36439271 |
| 24 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.34114163 |
| 25 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.32974863 |
| 26 | modulation by virus of host process (GO:0019054) | 3.30978087 |
| 27 | GDP-mannose metabolic process (GO:0019673) | 3.30937788 |
| 28 | translational initiation (GO:0006413) | 3.29499163 |
| 29 | heme biosynthetic process (GO:0006783) | 3.25135447 |
| 30 | cellular component biogenesis (GO:0044085) | 3.24782567 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.22209344 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.22209344 |
| 33 | protein targeting to ER (GO:0045047) | 3.20848367 |
| 34 | DNA unwinding involved in DNA replication (GO:0006268) | 3.20648214 |
| 35 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.19724918 |
| 36 | cotranslational protein targeting to membrane (GO:0006613) | 3.19706972 |
| 37 | IMP biosynthetic process (GO:0006188) | 3.16700448 |
| 38 | protein targeting to mitochondrion (GO:0006626) | 3.14186554 |
| 39 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.14079758 |
| 40 | regulation of protein heterodimerization activity (GO:0043497) | 3.14023508 |
| 41 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.13674727 |
| 42 | UV protection (GO:0009650) | 3.11978139 |
| 43 | mitotic recombination (GO:0006312) | 3.10815017 |
| 44 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.09685858 |
| 45 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.07896801 |
| 46 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.07170490 |
| 47 | proline biosynthetic process (GO:0006561) | 3.06942995 |
| 48 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.05983763 |
| 49 | ATP synthesis coupled proton transport (GO:0015986) | 3.05983763 |
| 50 | nucleobase biosynthetic process (GO:0046112) | 3.05581466 |
| 51 | NIK/NF-kappaB signaling (GO:0038061) | 3.05120886 |
| 52 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.03645316 |
| 53 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.03645316 |
| 54 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.03595902 |
| 55 | mitotic nuclear envelope disassembly (GO:0007077) | 3.02823863 |
| 56 | DNA replication checkpoint (GO:0000076) | 3.01502891 |
| 57 | protein localization to endoplasmic reticulum (GO:0070972) | 3.00616163 |
| 58 | ribosomal small subunit biogenesis (GO:0042274) | 3.00055223 |
| 59 | T cell apoptotic process (GO:0070231) | 2.99709503 |
| 60 | rRNA modification (GO:0000154) | 2.98913759 |
| 61 | protein localization to chromosome, centromeric region (GO:0071459) | 2.96199716 |
| 62 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.94810699 |
| 63 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.92276105 |
| 64 | telomere maintenance via telomere lengthening (GO:0010833) | 2.92229487 |
| 65 | viral life cycle (GO:0019058) | 2.90977496 |
| 66 | modulation by symbiont of host cellular process (GO:0044068) | 2.89384818 |
| 67 | establishment of protein localization to mitochondrion (GO:0072655) | 2.89350878 |
| 68 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.88630621 |
| 69 | cellular protein complex disassembly (GO:0043624) | 2.88543800 |
| 70 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.87162899 |
| 71 | ribosomal large subunit biogenesis (GO:0042273) | 2.86244807 |
| 72 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.85918095 |
| 73 | IMP metabolic process (GO:0046040) | 2.84884470 |
| 74 | pseudouridine synthesis (GO:0001522) | 2.84239772 |
| 75 | ribosome assembly (GO:0042255) | 2.83335694 |
| 76 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.83029360 |
| 77 | proteasome assembly (GO:0043248) | 2.82998822 |
| 78 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.81578291 |
| 79 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.79769331 |
| 80 | protein localization to mitochondrion (GO:0070585) | 2.79703966 |
| 81 | folic acid metabolic process (GO:0046655) | 2.79515263 |
| 82 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.78665973 |
| 83 | tetrapyrrole biosynthetic process (GO:0033014) | 2.78362231 |
| 84 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.77825709 |
| 85 | mitotic chromosome condensation (GO:0007076) | 2.76632361 |
| 86 | pentose-phosphate shunt (GO:0006098) | 2.75146021 |
| 87 | nuclear envelope disassembly (GO:0051081) | 2.74932956 |
| 88 | membrane disassembly (GO:0030397) | 2.74932956 |
| 89 | base-excision repair, AP site formation (GO:0006285) | 2.74594916 |
| 90 | cellular response to zinc ion (GO:0071294) | 2.73938592 |
| 91 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.72634307 |
| 92 | viral protein processing (GO:0019082) | 2.72340170 |
| 93 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.72149826 |
| 94 | mitochondrial fusion (GO:0008053) | 2.71305490 |
| 95 | porphyrin-containing compound metabolic process (GO:0006778) | 2.70170864 |
| 96 | regulation of mitochondrial translation (GO:0070129) | 2.69085258 |
| 97 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.68427355 |
| 98 | immunoglobulin mediated immune response (GO:0016064) | 2.67720061 |
| 99 | neutrophil activation involved in immune response (GO:0002283) | 2.67386533 |
| 100 | purine-containing compound salvage (GO:0043101) | 2.65511089 |
| 101 | B cell mediated immunity (GO:0019724) | 2.65327230 |
| 102 | ribosome biogenesis (GO:0042254) | 2.65118713 |
| 103 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.65037633 |
| 104 | positive regulation of protein homooligomerization (GO:0032464) | 2.65026918 |
| 105 | purine nucleobase biosynthetic process (GO:0009113) | 2.63865619 |
| 106 | translation (GO:0006412) | 2.62621156 |
| 107 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.62511210 |
| 108 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.62279719 |
| 109 | tRNA methylation (GO:0030488) | 2.61129335 |
| 110 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.60721512 |
| 111 | termination of RNA polymerase III transcription (GO:0006386) | 2.60721512 |
| 112 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.60498517 |
| 113 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.60375984 |
| 114 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.59889059 |
| 115 | ncRNA 3-end processing (GO:0043628) | 2.59211901 |
| 116 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.59183802 |
| 117 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.57403776 |
| 118 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.56683792 |
| 119 | heme metabolic process (GO:0042168) | 2.56081278 |
| 120 | establishment of protein localization to membrane (GO:0090150) | 2.55638705 |
| 121 | oxygen transport (GO:0015671) | 2.55117163 |
| 122 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.54990115 |
| 123 | protein complex disassembly (GO:0043241) | 2.54554834 |
| 124 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.54034346 |
| 125 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.53885658 |
| 126 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.53809699 |
| 127 | rRNA transcription (GO:0009303) | 2.53403750 |
| 128 | negative regulation of RNA splicing (GO:0033119) | 2.53103157 |
| 129 | rRNA processing (GO:0006364) | 2.52396859 |
| 130 | deoxyribonucleotide catabolic process (GO:0009264) | 2.51466357 |
| 131 | pentose metabolic process (GO:0019321) | 2.49881962 |
| 132 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.49823714 |
| 133 | natural killer cell mediated immunity (GO:0002228) | 2.49823714 |
| 134 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.49781202 |
| 135 | rRNA methylation (GO:0031167) | 2.49489201 |
| 136 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.48833424 |
| 137 | positive regulation of B cell differentiation (GO:0045579) | 2.48102522 |
| 138 | cellular response to virus (GO:0098586) | 2.47835378 |
| 139 | cell cycle G1/S phase transition (GO:0044843) | 2.47311270 |
| 140 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.47311270 |
| 141 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.46277508 |
| 142 | lymphocyte apoptotic process (GO:0070227) | 2.45309974 |
| 143 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.43972420 |
| 144 | rRNA metabolic process (GO:0016072) | 2.43019428 |
| 145 | negative regulation of ligase activity (GO:0051352) | 2.42783994 |
| 146 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.42783994 |
| 147 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.41457486 |
| 148 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.40318708 |
| 149 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.40318708 |
| 150 | RNA catabolic process (GO:0006401) | 2.40292900 |
| 151 | CENP-A containing nucleosome assembly (GO:0034080) | 2.38833177 |
| 152 | mRNA catabolic process (GO:0006402) | 2.38594201 |
| 153 | macromolecular complex disassembly (GO:0032984) | 2.37382447 |
| 154 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.36149074 |
| 155 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.36149074 |
| 156 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.36149074 |
| 157 | regulation of translational termination (GO:0006449) | 2.36043990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.04942604 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.22760891 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.45759374 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.76395412 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.64730470 |
| 6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.50441567 |
| 7 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.45711029 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.40419364 |
| 9 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.35995072 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.33445865 |
| 11 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.31769072 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.29422085 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.28308932 |
| 14 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.24648188 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.23998439 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.23122235 |
| 17 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.19750446 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.19420939 |
| 19 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.14233505 |
| 20 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.10590515 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.06845793 |
| 22 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00625297 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.98126974 |
| 24 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.97891023 |
| 25 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.97725809 |
| 26 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.95011881 |
| 27 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.89449121 |
| 28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.89300734 |
| 29 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.86911680 |
| 30 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.84215415 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.83538551 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83445740 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.79509790 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.76815635 |
| 35 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.75458250 |
| 36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.74566535 |
| 37 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.71557641 |
| 38 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.68963729 |
| 39 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66737655 |
| 40 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.66217084 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.63084548 |
| 42 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.60705006 |
| 43 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.59746197 |
| 44 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.59190099 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.59121344 |
| 46 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.58059391 |
| 47 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.56695898 |
| 48 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.51334543 |
| 49 | P68_20966046_ChIP-Seq_HELA_Human | 1.46838807 |
| 50 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.46785415 |
| 51 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.45483044 |
| 52 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.45349419 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.44739125 |
| 54 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.43351432 |
| 55 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.43333473 |
| 56 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.43036945 |
| 57 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.42670308 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41865886 |
| 59 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.41498617 |
| 60 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.39312551 |
| 61 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.38534442 |
| 62 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.37843469 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.37731568 |
| 64 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36430334 |
| 65 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.35657666 |
| 66 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32965983 |
| 67 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.32909691 |
| 68 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.32268660 |
| 69 | MAF_26560356_Chip-Seq_TH1_Human | 1.32015408 |
| 70 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30929642 |
| 71 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.30871813 |
| 72 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.30545194 |
| 73 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.29970374 |
| 74 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.28386188 |
| 75 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.27717988 |
| 76 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.27626650 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27425007 |
| 78 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.27302809 |
| 79 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.25580428 |
| 80 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24319651 |
| 81 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.24319330 |
| 82 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.23891446 |
| 83 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21232163 |
| 84 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.20924155 |
| 85 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.20812402 |
| 86 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.20749009 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20087565 |
| 88 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.20038868 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.19572209 |
| 90 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.19188879 |
| 91 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18935133 |
| 92 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.17752973 |
| 93 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17620829 |
| 94 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.17389200 |
| 95 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.17218070 |
| 96 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17060003 |
| 97 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.16028644 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15431469 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14715963 |
| 100 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14187965 |
| 101 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.13903484 |
| 102 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13888116 |
| 103 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13207555 |
| 104 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12312652 |
| 105 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12058619 |
| 106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11408620 |
| 107 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.11344070 |
| 108 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.11040614 |
| 109 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.10706720 |
| 110 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.10493823 |
| 111 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.10053935 |
| 112 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09720175 |
| 113 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08629567 |
| 114 | MYB_26560356_Chip-Seq_TH2_Human | 1.08553959 |
| 115 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07881529 |
| 116 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07672733 |
| 117 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07424735 |
| 118 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.06825246 |
| 119 | MYB_26560356_Chip-Seq_TH1_Human | 1.06577263 |
| 120 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06350782 |
| 121 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.06251648 |
| 122 | UTX_26944678_Chip-Seq_JUKART_Human | 1.06135645 |
| 123 | MAF_26560356_Chip-Seq_TH2_Human | 1.04924691 |
| 124 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02537401 |
| 125 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02279234 |
| 126 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.94620073 |
| 127 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94145219 |
| 128 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.94024600 |
| 129 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93398530 |
| 130 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91708843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 3.79410079 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.30360097 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.17729876 |
| 4 | MP0002396_abnormal_hematopoietic_system | 3.09357308 |
| 5 | MP0003111_abnormal_nucleus_morphology | 2.76334210 |
| 6 | MP0005451_abnormal_body_composition | 2.73274920 |
| 7 | MP0010094_abnormal_chromosome_stability | 2.70249024 |
| 8 | MP0003656_abnormal_erythrocyte_physiolo | 2.62686190 |
| 9 | * MP0000685_abnormal_immune_system | 2.55049174 |
| 10 | MP0005397_hematopoietic_system_phenotyp | 2.51076570 |
| 11 | MP0001545_abnormal_hematopoietic_system | 2.51076570 |
| 12 | MP0003077_abnormal_cell_cycle | 2.49672219 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 2.48376079 |
| 14 | MP0003436_decreased_susceptibility_to | 2.28158347 |
| 15 | MP0008057_abnormal_DNA_replication | 2.25562103 |
| 16 | MP0010307_abnormal_tumor_latency | 2.17248789 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.08205925 |
| 18 | MP0000490_abnormal_crypts_of | 2.06589897 |
| 19 | MP0008260_abnormal_autophagy | 2.03199412 |
| 20 | MP0004808_abnormal_hematopoietic_stem | 2.02468113 |
| 21 | MP0004233_abnormal_muscle_weight | 1.99764279 |
| 22 | * MP0002398_abnormal_bone_marrow | 1.96747171 |
| 23 | MP0005671_abnormal_response_to | 1.96515315 |
| 24 | MP0001800_abnormal_humoral_immune | 1.94370658 |
| 25 | MP0009785_altered_susceptibility_to | 1.93753688 |
| 26 | MP0006054_spinal_hemorrhage | 1.92899931 |
| 27 | MP0008007_abnormal_cellular_replicative | 1.92182088 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.92121576 |
| 29 | MP0002163_abnormal_gland_morphology | 1.91499950 |
| 30 | MP0002452_abnormal_antigen_presenting | 1.90845504 |
| 31 | MP0001853_heart_inflammation | 1.90597360 |
| 32 | MP0008058_abnormal_DNA_repair | 1.88900316 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.87404259 |
| 34 | MP0010352_gastrointestinal_tract_polyps | 1.83463336 |
| 35 | MP0005025_abnormal_response_to | 1.82771313 |
| 36 | MP0002419_abnormal_innate_immunity | 1.76247222 |
| 37 | MP0001819_abnormal_immune_cell | 1.74007476 |
| 38 | * MP0000689_abnormal_spleen_morphology | 1.73759219 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.73044676 |
| 40 | * MP0002723_abnormal_immune_serum | 1.71357426 |
| 41 | MP0001790_abnormal_immune_system | 1.71192155 |
| 42 | MP0005387_immune_system_phenotype | 1.71192155 |
| 43 | MP0005058_abnormal_lysosome_morphology | 1.71078320 |
| 44 | * MP0002722_abnormal_immune_system | 1.67847535 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.63467094 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.62710916 |
| 47 | MP0001348_abnormal_lacrimal_gland | 1.62435409 |
| 48 | * MP0002429_abnormal_blood_cell | 1.61428765 |
| 49 | * MP0000716_abnormal_immune_system | 1.61084562 |
| 50 | MP0000858_altered_metastatic_potential | 1.56367669 |
| 51 | MP0003303_peritoneal_inflammation | 1.49720548 |
| 52 | MP0002405_respiratory_system_inflammati | 1.45975181 |
| 53 | MP0004147_increased_porphyrin_level | 1.45718130 |
| 54 | MP0003763_abnormal_thymus_physiology | 1.45336247 |
| 55 | MP0002132_abnormal_respiratory_system | 1.43204717 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.42935453 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.42768930 |
| 58 | MP0009278_abnormal_bone_marrow | 1.40154977 |
| 59 | MP0000350_abnormal_cell_proliferation | 1.36042479 |
| 60 | MP0003186_abnormal_redox_activity | 1.30420463 |
| 61 | * MP0000313_abnormal_cell_death | 1.28389832 |
| 62 | MP0005076_abnormal_cell_differentiation | 1.27107329 |
| 63 | MP0004510_myositis | 1.27105848 |
| 64 | MP0002006_tumorigenesis | 1.25206513 |
| 65 | * MP0000703_abnormal_thymus_morphology | 1.24672053 |
| 66 | MP0000678_abnormal_parathyroid_gland | 1.22853312 |
| 67 | MP0008932_abnormal_embryonic_tissue | 1.22613316 |
| 68 | MP0003866_abnormal_defecation | 1.20894203 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.20303015 |
| 70 | MP0006082_CNS_inflammation | 1.19452731 |
| 71 | MP0005501_abnormal_skin_physiology | 1.18605582 |
| 72 | MP0009840_abnormal_foam_cell | 1.18368470 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.17987113 |
| 74 | MP0005174_abnormal_tail_pigmentation | 1.14287116 |
| 75 | MP0003959_abnormal_lean_body | 1.13468398 |
| 76 | MP0001730_embryonic_growth_arrest | 1.13125099 |
| 77 | MP0003448_altered_tumor_morphology | 1.12701181 |
| 78 | MP0001873_stomach_inflammation | 1.11788718 |
| 79 | MP0010155_abnormal_intestine_physiology | 1.08666229 |
| 80 | * MP0008469_abnormal_protein_level | 1.07076157 |
| 81 | MP0001533_abnormal_skeleton_physiology | 1.06651283 |
| 82 | MP0001661_extended_life_span | 1.03705961 |
| 83 | MP0003724_increased_susceptibility_to | 1.03662111 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 1.03613039 |
| 85 | MP0001905_abnormal_dopamine_level | 1.03196572 |
| 86 | * MP0006035_abnormal_mitochondrial_morpho | 1.00670038 |
| 87 | MP0003183_abnormal_peptide_metabolism | 1.00097104 |
| 88 | MP0000343_altered_response_to | 0.99996339 |
| 89 | MP0004947_skin_inflammation | 0.99218207 |
| 90 | MP0010030_abnormal_orbit_morphology | 0.98613232 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.98336282 |
| 92 | MP0003786_premature_aging | 0.97661108 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 0.96410651 |
| 94 | MP0009764_decreased_sensitivity_to | 0.95827842 |
| 95 | MP0003705_abnormal_hypodermis_morpholog | 0.95314093 |
| 96 | MP0002080_prenatal_lethality | 0.94285829 |
| 97 | MP0008438_abnormal_cutaneous_collagen | 0.94264408 |
| 98 | MP0005023_abnormal_wound_healing | 0.92820640 |
| 99 | * MP0000358_abnormal_cell_content/ | 0.88218726 |
| 100 | MP0003806_abnormal_nucleotide_metabolis | 0.87594701 |
| 101 | MP0001915_intracranial_hemorrhage | 0.84145125 |
| 102 | MP0000750_abnormal_muscle_regeneration | 0.84131894 |
| 103 | MP0000371_diluted_coat_color | 0.84032622 |
| 104 | MP0001697_abnormal_embryo_size | 0.83600194 |
| 105 | MP0002210_abnormal_sex_determination | 0.83370435 |
| 106 | MP0005621_abnormal_cell_physiology | 0.81701641 |
| 107 | MP0005310_abnormal_salivary_gland | 0.80700439 |
| 108 | MP0009931_abnormal_skin_appearance | 0.79759861 |
| 109 | MP0000015_abnormal_ear_pigmentation | 0.78565255 |
| 110 | MP0001727_abnormal_embryo_implantation | 0.78401120 |
| 111 | MP0000465_gastrointestinal_hemorrhage | 0.77902992 |
| 112 | MP0005075_abnormal_melanosome_morpholog | 0.75632200 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.75465942 |
| 114 | MP0008995_early_reproductive_senescence | 0.75428485 |
| 115 | MP0006292_abnormal_olfactory_placode | 0.75368091 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.74574021 |
| 117 | MP0003123_paternal_imprinting | 0.74398115 |
| 118 | MP0009763_increased_sensitivity_to | 0.74109180 |
| 119 | MP0000598_abnormal_liver_morphology | 0.73811759 |
| 120 | MP0002138_abnormal_hepatobiliary_system | 0.73448174 |
| 121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.73384007 |
| 122 | MP0000681_abnormal_thyroid_gland | 0.72365324 |
| 123 | MP0003984_embryonic_growth_retardation | 0.72290504 |
| 124 | MP0005083_abnormal_biliary_tract | 0.71285033 |
| 125 | * MP0005384_cellular_phenotype | 0.71025565 |
| 126 | MP0000609_abnormal_liver_physiology | 0.70522981 |
| 127 | MP0002086_abnormal_extraembryonic_tissu | 0.70359108 |
| 128 | MP0002088_abnormal_embryonic_growth/wei | 0.69590771 |
| 129 | MP0003191_abnormal_cellular_cholesterol | 0.69280415 |
| 130 | MP0006036_abnormal_mitochondrial_physio | 0.69124117 |
| 131 | MP0001672_abnormal_embryogenesis/_devel | 0.66869205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal number of erythroid precursors (HP:0012131) | 4.96369415 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.91441224 |
| 3 | Thrombocytosis (HP:0001894) | 4.22381951 |
| 4 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.05075319 |
| 5 | Reticulocytopenia (HP:0001896) | 3.56089624 |
| 6 | Recurrent abscess formation (HP:0002722) | 3.55790765 |
| 7 | Petechiae (HP:0000967) | 3.37301318 |
| 8 | Aplastic anemia (HP:0001915) | 3.32016580 |
| 9 | Agammaglobulinemia (HP:0004432) | 3.24970285 |
| 10 | Birth length less than 3rd percentile (HP:0003561) | 3.14004121 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.12813785 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.11465622 |
| 13 | Abnormal hemoglobin (HP:0011902) | 3.07648598 |
| 14 | Pallor (HP:0000980) | 3.05789053 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 2.90810588 |
| 16 | Hypertensive crisis (HP:0100735) | 2.85871771 |
| 17 | Eczematoid dermatitis (HP:0000976) | 2.80377248 |
| 18 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.78711490 |
| 19 | Myositis (HP:0100614) | 2.75259295 |
| 20 | Chronic otitis media (HP:0000389) | 2.70802456 |
| 21 | Vertebral compression fractures (HP:0002953) | 2.70451254 |
| 22 | Increased muscle lipid content (HP:0009058) | 2.69081621 |
| 23 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.68462755 |
| 24 | Esophageal neoplasm (HP:0100751) | 2.65155708 |
| 25 | Neoplasm of head and neck (HP:0012288) | 2.65155708 |
| 26 | Abnormality of reticulocytes (HP:0004312) | 2.62001144 |
| 27 | Poor head control (HP:0002421) | 2.61127873 |
| 28 | Increased intramyocellular lipid droplets (HP:0012240) | 2.60902043 |
| 29 | Gastrointestinal stroma tumor (HP:0100723) | 2.59138974 |
| 30 | Progressive muscle weakness (HP:0003323) | 2.58961960 |
| 31 | Increased serum ferritin (HP:0003281) | 2.58859708 |
| 32 | Abnormality of T cell physiology (HP:0011840) | 2.56473779 |
| 33 | Cholelithiasis (HP:0001081) | 2.56234961 |
| 34 | IgM deficiency (HP:0002850) | 2.54791426 |
| 35 | Recurrent viral infections (HP:0004429) | 2.50963218 |
| 36 | Abnormal gallbladder physiology (HP:0012438) | 2.50195512 |
| 37 | Cholecystitis (HP:0001082) | 2.50195512 |
| 38 | Selective tooth agenesis (HP:0001592) | 2.49048613 |
| 39 | Mediastinal lymphadenopathy (HP:0100721) | 2.48177748 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.45718661 |
| 41 | Panhypogammaglobulinemia (HP:0003139) | 2.45134981 |
| 42 | Purpura (HP:0000979) | 2.39309349 |
| 43 | Recurrent fungal infections (HP:0002841) | 2.36926980 |
| 44 | Oral leukoplakia (HP:0002745) | 2.35672536 |
| 45 | Entropion (HP:0000621) | 2.35301857 |
| 46 | Truncus arteriosus (HP:0001660) | 2.34743109 |
| 47 | Hyperthyroidism (HP:0000836) | 2.33302378 |
| 48 | Microretrognathia (HP:0000308) | 2.33078777 |
| 49 | Paralysis (HP:0003470) | 2.31538810 |
| 50 | Macrocytic anemia (HP:0001972) | 2.30880093 |
| 51 | Mitochondrial inheritance (HP:0001427) | 2.30170123 |
| 52 | Cellulitis (HP:0100658) | 2.29626186 |
| 53 | Acute necrotizing encephalopathy (HP:0006965) | 2.29565122 |
| 54 | Poikiloderma (HP:0001029) | 2.28533590 |
| 55 | Broad distal phalanx of finger (HP:0009836) | 2.26176792 |
| 56 | Recurrent cutaneous fungal infections (HP:0011370) | 2.25881944 |
| 57 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.25881944 |
| 58 | Myelodysplasia (HP:0002863) | 2.23752719 |
| 59 | Acute encephalopathy (HP:0006846) | 2.22958176 |
| 60 | Agnosia (HP:0010524) | 2.22255270 |
| 61 | Microvesicular hepatic steatosis (HP:0001414) | 2.22075247 |
| 62 | Polycythemia (HP:0001901) | 2.21346306 |
| 63 | Amaurosis fugax (HP:0100576) | 2.18721877 |
| 64 | Hepatocellular necrosis (HP:0001404) | 2.18422978 |
| 65 | Pustule (HP:0200039) | 2.17584534 |
| 66 | Seborrheic dermatitis (HP:0001051) | 2.16922240 |
| 67 | Increased IgM level (HP:0003496) | 2.16628886 |
| 68 | Ragged-red muscle fibers (HP:0003200) | 2.16297465 |
| 69 | Exertional dyspnea (HP:0002875) | 2.15144155 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.14856823 |
| 71 | Granulocytopenia (HP:0001913) | 2.12194395 |
| 72 | Microcytic anemia (HP:0001935) | 2.11278068 |
| 73 | Fatigue (HP:0012378) | 2.10435144 |
| 74 | Nausea (HP:0002018) | 2.09597596 |
| 75 | Reticulocytosis (HP:0001923) | 2.09076374 |
| 76 | Exercise intolerance (HP:0003546) | 2.08621692 |
| 77 | Prolonged bleeding time (HP:0003010) | 2.08519818 |
| 78 | Slender long bone (HP:0003100) | 2.08194286 |
| 79 | Hypokinesia (HP:0002375) | 2.08037750 |
| 80 | Epistaxis (HP:0000421) | 2.07891237 |
| 81 | Abnormal platelet function (HP:0011869) | 2.07745803 |
| 82 | Impaired platelet aggregation (HP:0003540) | 2.07745803 |
| 83 | Abnormality of the thoracic spine (HP:0100711) | 2.06886572 |
| 84 | Albinism (HP:0001022) | 2.06041396 |
| 85 | Abnormality of iron homeostasis (HP:0011031) | 2.05488033 |
| 86 | Type I transferrin isoform profile (HP:0003642) | 2.03896824 |
| 87 | Prolonged neonatal jaundice (HP:0006579) | 2.01619429 |
| 88 | Rough bone trabeculation (HP:0100670) | 2.01448604 |
| 89 | Squamous cell carcinoma (HP:0002860) | 2.00972093 |
| 90 | Increased IgE level (HP:0003212) | 2.00624332 |
| 91 | Respiratory difficulties (HP:0002880) | 2.00612180 |
| 92 | Opisthotonus (HP:0002179) | 1.99642081 |
| 93 | Hepatic necrosis (HP:0002605) | 1.99086142 |
| 94 | Abnormal gallbladder morphology (HP:0012437) | 1.98899214 |
| 95 | Increased CSF lactate (HP:0002490) | 1.98802076 |
| 96 | Hypoparathyroidism (HP:0000829) | 1.98786658 |
| 97 | Multiple enchondromatosis (HP:0005701) | 1.97251094 |
| 98 | Pulmonary fibrosis (HP:0002206) | 1.97126209 |
| 99 | Increased serum lactate (HP:0002151) | 1.95693455 |
| 100 | Basal ganglia calcification (HP:0002135) | 1.93711381 |
| 101 | Hypochromic anemia (HP:0001931) | 1.93643234 |
| 102 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.93046262 |
| 103 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.93046262 |
| 104 | Abnormality of DNA repair (HP:0003254) | 1.92808861 |
| 105 | Lymphoma (HP:0002665) | 1.92719013 |
| 106 | Nonimmune hydrops fetalis (HP:0001790) | 1.91719850 |
| 107 | Orchitis (HP:0100796) | 1.91582777 |
| 108 | Recurrent skin infections (HP:0001581) | 1.91248949 |
| 109 | Recurrent bronchitis (HP:0002837) | 1.91105569 |
| 110 | Degeneration of anterior horn cells (HP:0002398) | 1.91064197 |
| 111 | Abnormality of the anterior horn cell (HP:0006802) | 1.91064197 |
| 112 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.90517856 |
| 113 | Vasculitis (HP:0002633) | 1.90194689 |
| 114 | Vacuolated lymphocytes (HP:0001922) | 1.89693715 |
| 115 | Pancytopenia (HP:0001876) | 1.89533939 |
| 116 | Interstitial pulmonary disease (HP:0006530) | 1.88773739 |
| 117 | Neutropenia (HP:0001875) | 1.88573010 |
| 118 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.88447139 |
| 119 | Renal Fanconi syndrome (HP:0001994) | 1.88427930 |
| 120 | Hypertriglyceridemia (HP:0002155) | 1.87974145 |
| 121 | Abnormality of T cells (HP:0002843) | 1.87747507 |
| 122 | Gastrointestinal infarctions (HP:0005244) | 1.87650121 |
| 123 | Abnormality of the nasal mucosa (HP:0000433) | 1.86419702 |
| 124 | Abnormality of lateral ventricle (HP:0030047) | 1.86289190 |
| 125 | Ileus (HP:0002595) | 1.86046472 |
| 126 | Abnormality of the gallbladder (HP:0005264) | 1.85116418 |
| 127 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85033246 |
| 128 | Peritonitis (HP:0002586) | 1.84413892 |
| 129 | Colitis (HP:0002583) | 1.84203417 |
| 130 | Cervical subluxation (HP:0003308) | 1.83613995 |
| 131 | Achilles tendon contracture (HP:0001771) | 1.83474992 |
| 132 | Cutaneous photosensitivity (HP:0000992) | 1.83344783 |
| 133 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.82880706 |
| 134 | Joint stiffness (HP:0001387) | 1.82828267 |
| 135 | Nasal polyposis (HP:0100582) | 1.82426478 |
| 136 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.82133085 |
| 137 | Osteolytic defects of the hand bones (HP:0009699) | 1.82133085 |
| 138 | Increased serum pyruvate (HP:0003542) | 1.81390975 |
| 139 | Biconcave vertebral bodies (HP:0004586) | 1.81199105 |
| 140 | Lactic acidosis (HP:0003128) | 1.80786300 |
| 141 | Poikilocytosis (HP:0004447) | 1.80727335 |
| 142 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.80169983 |
| 143 | Chest pain (HP:0100749) | 1.79142554 |
| 144 | Premature graying of hair (HP:0002216) | 1.78392445 |
| 145 | Obstructive lung disease (HP:0006536) | 1.77735767 |
| 146 | Chronic obstructive pulmonary disease (HP:0006510) | 1.77735767 |
| 147 | Encephalitis (HP:0002383) | 1.77493486 |
| 148 | Meningitis (HP:0001287) | 1.77377123 |
| 149 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.77345513 |
| 150 | Muscle fiber atrophy (HP:0100295) | 1.77228923 |
| 151 | Urticaria (HP:0001025) | 1.77108702 |
| 152 | Arterial thrombosis (HP:0004420) | 1.76181759 |
| 153 | Breast hypoplasia (HP:0003187) | 1.75624969 |
| 154 | Reduced antithrombin III activity (HP:0001976) | 1.74848864 |
| 155 | Hypoplasia of the pons (HP:0012110) | 1.74483649 |
| 156 | Gastrointestinal inflammation (HP:0004386) | 1.71761840 |
| 157 | Protrusio acetabuli (HP:0003179) | 1.71276124 |
| 158 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.71096562 |
| 159 | Increased cerebral lipofuscin (HP:0011813) | 1.71013537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.25826982 |
| 2 | PIM2 | 3.03331011 |
| 3 | BUB1 | 2.86987252 |
| 4 | WEE1 | 2.77811810 |
| 5 | TRIB3 | 2.47626079 |
| 6 | EIF2AK1 | 2.44149462 |
| 7 | PRPF4B | 2.43405217 |
| 8 | SMG1 | 2.39386674 |
| 9 | MAP4K1 | 2.06730698 |
| 10 | VRK2 | 1.98672428 |
| 11 | PKN2 | 1.98240919 |
| 12 | ERN1 | 1.98233533 |
| 13 | CDC7 | 1.93721390 |
| 14 | EEF2K | 1.92841736 |
| 15 | NEK2 | 1.92721236 |
| 16 | ACVR1B | 1.91326520 |
| 17 | SCYL2 | 1.90109153 |
| 18 | BRSK2 | 1.89734341 |
| 19 | RPS6KA4 | 1.89412765 |
| 20 | TYK2 | 1.87050161 |
| 21 | TBK1 | 1.83436231 |
| 22 | MAPKAPK3 | 1.74422073 |
| 23 | JAK3 | 1.70453818 |
| 24 | KIT | 1.64248968 |
| 25 | FLT3 | 1.61769983 |
| 26 | MAP3K10 | 1.60703395 |
| 27 | TAF1 | 1.58365105 |
| 28 | BLK | 1.55464904 |
| 29 | STK16 | 1.48572658 |
| 30 | MAP3K11 | 1.43654191 |
| 31 | IKBKB | 1.43319228 |
| 32 | ZAP70 | 1.39036649 |
| 33 | EIF2AK3 | 1.38915006 |
| 34 | PIM1 | 1.38490342 |
| 35 | MAP3K14 | 1.38096096 |
| 36 | LRRK2 | 1.37938726 |
| 37 | PAK4 | 1.30948658 |
| 38 | TESK2 | 1.30241804 |
| 39 | NEK1 | 1.28117127 |
| 40 | TGFBR1 | 1.27740441 |
| 41 | MAP3K1 | 1.26722969 |
| 42 | KDR | 1.24886049 |
| 43 | VRK1 | 1.20786766 |
| 44 | MAP3K8 | 1.20151922 |
| 45 | MAP2K3 | 1.18481399 |
| 46 | DYRK3 | 1.18385196 |
| 47 | RPS6KB2 | 1.16952659 |
| 48 | BTK | 1.15757030 |
| 49 | STK10 | 1.14049689 |
| 50 | ZAK | 1.13900925 |
| 51 | BRSK1 | 1.12847748 |
| 52 | CDK8 | 1.12803007 |
| 53 | CSF1R | 1.10636040 |
| 54 | RPS6KA5 | 1.08383743 |
| 55 | IRAK4 | 1.06702035 |
| 56 | ATR | 1.06670571 |
| 57 | CDK4 | 1.04084926 |
| 58 | STK4 | 1.01481034 |
| 59 | PLK1 | 1.00427524 |
| 60 | SYK | 1.00179695 |
| 61 | CDK7 | 0.99461788 |
| 62 | SIK1 | 0.98962712 |
| 63 | TTN | 0.98930507 |
| 64 | MAP3K13 | 0.98847804 |
| 65 | TSSK6 | 0.95607521 |
| 66 | AURKB | 0.94533829 |
| 67 | FGFR4 | 0.92219796 |
| 68 | KSR2 | 0.92013294 |
| 69 | ICK | 0.91359534 |
| 70 | TAOK1 | 0.88630982 |
| 71 | MAP3K3 | 0.88392102 |
| 72 | NEK9 | 0.87692545 |
| 73 | FES | 0.87590257 |
| 74 | DAPK1 | 0.85549649 |
| 75 | EPHB1 | 0.81751953 |
| 76 | DAPK3 | 0.79287309 |
| 77 | TESK1 | 0.78740741 |
| 78 | ARAF | 0.78474890 |
| 79 | MATK | 0.78088450 |
| 80 | PLK4 | 0.77206329 |
| 81 | TGFBR2 | 0.76945631 |
| 82 | DYRK2 | 0.76064522 |
| 83 | PDK2 | 0.75308104 |
| 84 | CDK19 | 0.75117314 |
| 85 | IKBKE | 0.73824723 |
| 86 | BMX | 0.73797527 |
| 87 | ILK | 0.72891484 |
| 88 | RIPK4 | 0.72616568 |
| 89 | CHUK | 0.70600689 |
| 90 | SRPK1 | 0.69973627 |
| 91 | IRAK3 | 0.69729744 |
| 92 | RAF1 | 0.69537322 |
| 93 | NME1 | 0.69435568 |
| 94 | MAPK11 | 0.69267874 |
| 95 | ABL2 | 0.69155580 |
| 96 | MAPKAPK2 | 0.68045360 |
| 97 | GRK6 | 0.67521528 |
| 98 | LYN | 0.66851576 |
| 99 | MOS | 0.66234034 |
| 100 | BCKDK | 0.65511188 |
| 101 | MAP2K2 | 0.65367614 |
| 102 | TEC | 0.64442543 |
| 103 | PAK1 | 0.63889494 |
| 104 | AURKA | 0.60543622 |
| 105 | SIK2 | 0.58671319 |
| 106 | TLK1 | 0.57897519 |
| 107 | TAOK3 | 0.56142426 |
| 108 | IRAK2 | 0.56000628 |
| 109 | EIF2AK2 | 0.55912678 |
| 110 | RPS6KA6 | 0.54547020 |
| 111 | NTRK1 | 0.53360013 |
| 112 | PRKD2 | 0.53068471 |
| 113 | MARK3 | 0.52537783 |
| 114 | DYRK1B | 0.51162753 |
| 115 | BRAF | 0.49644980 |
| 116 | CHEK1 | 0.49244435 |
| 117 | TRPM7 | 0.48830117 |
| 118 | CCNB1 | 0.48033780 |
| 119 | CHEK2 | 0.47160320 |
| 120 | JAK1 | 0.46659534 |
| 121 | RPS6KL1 | 0.46109460 |
| 122 | RPS6KC1 | 0.46109460 |
| 123 | JAK2 | 0.45599262 |
| 124 | PRKCI | 0.45572822 |
| 125 | CDK6 | 0.45154956 |
| 126 | MAP3K6 | 0.44373907 |
| 127 | TAOK2 | 0.43978120 |
| 128 | LCK | 0.43755408 |
| 129 | TTK | 0.43206454 |
| 130 | MAP3K5 | 0.43084988 |
| 131 | MARK2 | 0.40814578 |
| 132 | HIPK2 | 0.39731010 |
| 133 | PDPK1 | 0.39493823 |
| 134 | RPS6KA2 | 0.37861695 |
| 135 | PKN1 | 0.35085405 |
| 136 | CSNK2A2 | 0.34092372 |
| 137 | RPS6KA1 | 0.32279713 |
| 138 | EPHA3 | 0.32257604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.58612817 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.40350189 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.06634330 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.03284159 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.96665524 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.35874131 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.35360052 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.28876597 |
| 9 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.17317239 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.11627199 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.08118771 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.02936256 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.01820061 |
| 14 | RNA transport_Homo sapiens_hsa03013 | 1.94750813 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.90391472 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.88700085 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.87999876 |
| 18 | Cell cycle_Homo sapiens_hsa04110 | 1.83268020 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.80600845 |
| 20 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.66662606 |
| 21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.62439125 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.55803779 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.51989321 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46706695 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44598104 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.35053404 |
| 27 | Sulfur relay system_Homo sapiens_hsa04122 | 1.30959046 |
| 28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.29671137 |
| 29 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.28187527 |
| 30 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.27687492 |
| 31 | Alcoholism_Homo sapiens_hsa05034 | 1.27135730 |
| 32 | * Apoptosis_Homo sapiens_hsa04210 | 1.26779610 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.26684312 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.26663179 |
| 35 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25575647 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.24760509 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.22413553 |
| 38 | RNA degradation_Homo sapiens_hsa03018 | 1.19664270 |
| 39 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.13607198 |
| 40 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.13387809 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11416130 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.10197203 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.06292791 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.05588184 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04402373 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99221080 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 0.98872638 |
| 48 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.98338411 |
| 49 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.96037115 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94397304 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.91685508 |
| 52 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.91439441 |
| 53 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.91106299 |
| 54 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.90677147 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88401147 |
| 56 | Bladder cancer_Homo sapiens_hsa05219 | 0.88275095 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.88108699 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86776654 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.86697079 |
| 60 | Purine metabolism_Homo sapiens_hsa00230 | 0.85963602 |
| 61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85732552 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83508973 |
| 63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.83125295 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82726623 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79921574 |
| 66 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.79798213 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78729380 |
| 68 | Tuberculosis_Homo sapiens_hsa05152 | 0.78672258 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77395052 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77162012 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77146037 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.75451348 |
| 73 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73250951 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72965413 |
| 75 | Malaria_Homo sapiens_hsa05144 | 0.72170306 |
| 76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72085611 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71906410 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70860041 |
| 79 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68814233 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68008487 |
| 81 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66907812 |
| 82 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65410256 |
| 83 | Lysosome_Homo sapiens_hsa04142 | 0.65116411 |
| 84 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64547204 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63665474 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61893947 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.61094792 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59968382 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59622942 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59127952 |
| 91 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.57386078 |
| 92 | Asthma_Homo sapiens_hsa05310 | 0.56824282 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56280080 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56221605 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55683309 |
| 96 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.54680335 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.53500860 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52913914 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52804850 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50747875 |
| 101 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.49096875 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.46880593 |
| 103 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46522549 |
| 104 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46122010 |
| 105 | Basal transcription factors_Homo sapiens_hsa03022 | 0.44994507 |
| 106 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44864306 |
| 107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.43404955 |
| 108 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.43119222 |
| 109 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.42891181 |
| 110 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.42023529 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41648115 |
| 112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41373873 |
| 113 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40562466 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40542621 |
| 115 | Hepatitis C_Homo sapiens_hsa05160 | 0.40539178 |
| 116 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40521234 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39654537 |
| 118 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39507148 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38865499 |
| 120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38725182 |
| 121 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38525308 |
| 122 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.38179265 |
| 123 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37582703 |
| 124 | Protein export_Homo sapiens_hsa03060 | 0.37248590 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.36911499 |
| 126 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.36443965 |
| 127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35068318 |
| 128 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.33322303 |
| 129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30000366 |

